হজকিন লিম্ফোমা

The main aim of this study is to check how safe brentuximab vedotin is in adults with untreated Hodgkin Lymphoma (HL) when given together with doxorubicin (Adriamycin), vinblastine and dacarbazine therapy ('AVD'). Another aim is to learn how well treatment of brentuximab vedotin plus AVD works. All participants will receive brentuximab vedotin plus AVD for approximately 6 months. Participants will undergo tests like Echocardiography (ECHO) and pulmonary function testing (PFT) during the study. ECHO is a test that uses ultrasound to show how the heart muscle and valves are working; PFT is a te…

স্পনসর: Takeda
ClinicalTrials.gov-এ NCT06831370
রেজিস্ট্রিতে শেষ আপডেট 23 Feb 2026 · আমাদের দ্বারা পড়া হয়েছে 20 Oct 2026